Search Results

There are 24583 results for: content related to: Racially restricted contribution of immunoglobulin Fc γ and Fc γ receptor genotypes to humoral immunity to human epidermal growth factor receptor 2 in breast cancer

  1. ScFv-Decorated PEG-PLA-Based Nanoparticles for Enhanced siRNA Delivery to Her2+ Breast Cancer

    Advanced Healthcare Materials

    Volume 3, Issue 11, November, 2014, Pages: 1792–1803, Shuang Dou, Xian-Zhu Yang, Meng-Hua Xiong, Chun-Yang Sun, Yan-Dan Yao, Yan-Hua Zhu and Jun Wang

    Version of Record online : 20 JUN 2014, DOI: 10.1002/adhm.201400037

  2. You have free access to this content
    Synergism from combined immunologic and pharmacologic inhibition of HER2 in vivo

    International Journal of Cancer

    Volume 126, Issue 12, 15 June 2010, Pages: 2893–2903, Michael A. Morse, Junping Wei, Zachary Hartman, Wenle Xia, Xiu-Rong Ren, Gangjun Lei, William T. Barry, Takuya Osada, Amy C. Hobeika, Sharon Peplinski, Haixiang Jiang, Gayathri R. Devi, Wei Chen, Neil Spector, Andrea Amalfitano, H. Kim Lyerly and Timothy M. Clay

    Version of Record online : 23 OCT 2009, DOI: 10.1002/ijc.24995

  3. You have full text access to this OnlineOpen article
    The assessment of HER2 status in breast cancer: the past, the present, and the future

    Pathology International

    Volume 66, Issue 6, June 2016, Pages: 313–324, Hiroaki Nitta, Brian D. Kelly, Craig Allred, Suzan Jewell, Peter Banks, Eslie Dennis and Thomas M. Grogan

    Version of Record online : 7 APR 2016, DOI: 10.1111/pin.12407

  4. You have free access to this content
    Biomarkers of drugs targeting HER-family signalling in cancer

    The Journal of Pathology

    Volume 232, Issue 2, January 2014, Pages: 219–229, Filippo Montemurro and Maurizio Scaltriti

    Version of Record online : 10 DEC 2013, DOI: 10.1002/path.4269

  5. Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas

    The Journal of Pathology

    Volume 229, Issue 1, January 2013, Pages: 111–120, Michael S Anglesio, Stefan Kommoss, Mary C Tolcher, Blaise Clarke, Laura Galletta, Henry Porter, Sambasivarao Damaraju, Sian Fereday, Boris J Winterhoff, Steve E Kalloger, Janine Senz, Winnie Yang, Helen Steed, Ghassan Allo, Sarah Ferguson, Patricia Shaw, Attila Teoman, Joaquin J Garcia, John K Schoolmeester, Jamie Bakkum-Gamez, Anna V Tinker, David D Bowtell, David G Huntsman, C Blake Gilks and Jessica N McAlpine

    Version of Record online : 17 DEC 2012, DOI: 10.1002/path.4088

  6. The significance of HER-2/neu receptor positivity and immunophenotype in ductal carcinoma in situ with early invasive disease

    Journal of Surgical Oncology

    Volume 104, Issue 5, 1 October 2011, Pages: 458–465, Shuko Harada, Rosemarie Mick, Robert E. Roses, Holly Graves, Huilin Niu, Anupama Sharma, Jeanne E. Schueller, Harvey Nisenbaum, Brian J. Czerniecki and Paul J. Zhang

    Version of Record online : 9 MAY 2011, DOI: 10.1002/jso.21973

  7. You have full text access to this Open Access content
    Mechanisms of resistance to anti-human epidermal growth factor receptor 2 agents in breast cancer

    Cancer Science

    Volume 102, Issue 1, January 2011, Pages: 1–8, Toru Mukohara

    Version of Record online : 6 SEP 2010, DOI: 10.1111/j.1349-7006.2010.01711.x

  8. You have full text access to this OnlineOpen article
    High HER2 protein levels correlate with increased survival in breast cancer patients treated with anti-HER2 therapy

    Molecular Oncology

    Volume 10, Issue 1, January 2016, Pages: 138–147, Paolo Nuciforo, Sheeno Thyparambil, Claudia Aura, Ana Garrido-Castro, Marta Vilaro, Vicente Peg, José Jimenez, Rocio Vicario, Fabiola Cecchi, William Hoos, Jon Burrows, Todd Hembrough, Juan Carles Ferreres, José Perez-Garcia, Joaquin Arribas, Javier Cortes, Maurizio Scaltriti

    Version of Record online : 15 SEP 2015, DOI: 10.1016/j.molonc.2015.09.002

  9. Imaging EGFR and HER2 by PET and SPECT: A Review

    Medicinal Research Reviews

    Volume 34, Issue 3, May 2014, Pages: 596–643, Emily B. Corcoran and Robert N. Hanson

    Version of Record online : 29 AUG 2013, DOI: 10.1002/med.21299

  10. You have free access to this content
    Combinatorial treatment of mammospheres with trastuzumab and salinomycin efficiently targets HER2-positive cancer cells and cancer stem cells

    International Journal of Cancer

    Volume 131, Issue 12, 15 December 2012, Pages: 2808–2819, Prajakta S. Oak, Florian Kopp, Chitra Thakur, Joachim W. Ellwart, Ulf R. Rapp, Axel Ullrich, Ernst Wagner, Pjotr Knyazev and Andreas Roidl

    Version of Record online : 21 MAY 2012, DOI: 10.1002/ijc.27595

  11. You have free access to this content
    Comparison of intratumoral heterogeneity of HER2 expression between primary tumor and multiple organ metastases in gastric cancer: Clinicopathological study of three autopsy cases and one resected case

    Pathology International

    Volume 65, Issue 6, June 2015, Pages: 309–317, Takuya Saito, Chihiro Kondo, Kohei Shitara, Yuichi Ito, Noriko Saito, Yuzuru Ikehara, Yasushi Yatabe, Keigo Yamamichi, Hideo Tanaka and Hayao Nakanishi

    Version of Record online : 31 MAR 2015, DOI: 10.1111/pin.12290

  12. Biomedical Applications of Trastuzumab: As a Therapeutic Agent and a Targeting Ligand

    Medicinal Research Reviews

    Volume 35, Issue 4, July 2015, Pages: 849–876, Hitesh Kulhari, Deep Pooja, Sri V. K. Rompicharla, Ramakrishna Sistla and David J. Adams

    Version of Record online : 1 APR 2015, DOI: 10.1002/med.21345

  13. You have full text access to this OnlineOpen article
    Expression of CD24 is associated with HER2 expression and supports HER2-Akt signaling in HER2-positive breast cancer cells

    Cancer Science

    Volume 105, Issue 7, July 2014, Pages: 779–787, Mari Hosonaga, Yoshimi Arima, Eiji Sugihara, Norio Kohno and Hideyuki Saya

    Version of Record online : 1 JUN 2014, DOI: 10.1111/cas.12427

  14. You have free access to this content
    Cardiac toxicity in breast cancer patients treated with dual HER2 blockade

    International Journal of Cancer

    Volume 133, Issue 9, November 2013, Pages: 2245–2252, Antonis Valachis, Andreas Nearchou, Nikolaos P. Polyzos and Pehr Lind

    Version of Record online : 29 MAY 2013, DOI: 10.1002/ijc.28234

  15. You have full text access to this OnlineOpen article
    Clinical significance of glycoprotein nonmetastatic B and its association with HER2 in breast cancer

    Cancer Medicine

    Volume 4, Issue 9, September 2015, Pages: 1344–1355, Masako Kanematsu, Manabu Futamura, Masafumi Takata, Siqin Gaowa, Atsuko Yamada, Kasumi Morimitsu, Akemi Morikawa, Ryutaro Mori, Hideaki Hara and Kazuhiro Yoshida

    Version of Record online : 16 JUN 2015, DOI: 10.1002/cam4.480

  16. HER2 loss in HER2-positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical research

    International Journal of Cancer

    Volume 139, Issue 12, 15 December 2016, Pages: 2859–2864, F. Pietrantonio, M. Caporale, F. Morano, M. Scartozzi, A. Gloghini, F. De Vita, E. Giommoni, L. Fornaro, G. Aprile, D. Melisi, R. Berenato, A. Mennitto, C. C. Volpi, M. M. Laterza, V. Pusceddu, L. Antonuzzo, E. Vasile, E. Ongaro, F. Simionato, F. de Braud, V. Torri and M. Di Bartolomeo

    Version of Record online : 16 SEP 2016, DOI: 10.1002/ijc.30408

  17. You have free access to this content
    Quantitative HER2 protein levels predict outcome in fluorescence in situ hybridization-positive patients with metastatic breast cancer treated with trastuzumab

    Cancer

    Volume 116, Issue 22, 15 November 2010, Pages: 5168–5178, Allan Lipton, Wolfgang J. Köstler, Kim Leitzel, Suhail M. Ali, Jeff Sperinde, Jodi Weidler, Agnes Paquet, Thomas Sherwood, Weidong Huang, Michael Bates and the Trastuzumab Response Biomarker Group

    Version of Record online : 3 NOV 2010, DOI: 10.1002/cncr.25430

  18. You have full text access to this Open Access content
    The HER2 amplicon includes several genes required for the growth and survival of HER2 positive breast cancer cells

    Molecular Oncology

    Volume 7, Issue 3, June 2013, Pages: 392–401, Kristine Kleivi Sahlberg, Vesa Hongisto, Henrik Edgren, Rami Mäkelä, Kirsi Hellström, Eldri U. Due, Hans Kristian Moen Vollan, Niko Sahlberg, Maija Wolf, Anne-Lise Børresen-Dale, Merja Perälä, Olli Kallioniemi

    Version of Record online : 24 NOV 2012, DOI: 10.1016/j.molonc.2012.10.012

  19. You have free access to this content
    Cell membrane gp96 facilitates HER2 dimerization and serves as a novel target in breast cancer

    International Journal of Cancer

    Volume 137, Issue 3, 1 August 2015, Pages: 512–524, Xin Li, Lu Sun, Junwei Hou, Mingming Gui, Jianming Ying, Hong Zhao, Ning Lv and Songdong Meng

    Version of Record online : 8 JAN 2015, DOI: 10.1002/ijc.29405

  20. You have free access to this content
    Neural Stem Cells Secreting Anti-HER2 Antibody Improve Survival in a Preclinical Model of HER2 Overexpressing Breast Cancer Brain Metastases

    STEM CELLS

    Volume 33, Issue 10, October 2015, Pages: 2985–2994, Deepak Kanojia, Irina V. Balyasnikova, Ramin A. Morshed, Richard T. Frank, Dou Yu, Lingjiao Zhang, Drew A. Spencer, Julius W. Kim, Yu Han, Dihua Yu, Atique U. Ahmed, Karen S. Aboody and Maciej S. Lesniak

    Version of Record online : 11 AUG 2015, DOI: 10.1002/stem.2109